New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
05:55 EDTAON, AON, PRGO, PRGO, NWL, NWL, NOV, NOV, MRK, MRK, MAT, MAT, LYB, LYB, LM, LM, IR, IR, BEN, BEN, XOM, XOM, CVX, CVX, BEAM, BEAM, TSN, TSNCompanies reporting Before the Market Open on FridayFebruary 1
Notable companies reporting before the opening bell on Friday include Aon (AON), Beam (BEAM), Chevron (CVX), Exxon Mobil (XOM), Franklin Resources (BEN), Ingersoll-Rand (IR), Legg Mason (LM), LyondellBasell Industries (LYB), Mattel (MAT), Merck (MRK), National Oilwell Varco (NOV), Newell Rubbermaid (NWL), Perrigo (PRGO), and Tyson Foods (TSN).
News For AON;BEAM;CVX;XOM;BEN;IR;LM;LYB;MAT;MRK;NOV;NWL;PRGO;TSN From The Last 14 Days
Check below for free stories on AON;BEAM;CVX;XOM;BEN;IR;LM;LYB;MAT;MRK;NOV;NWL;PRGO;TSN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 9, 2014
11:43 EDTMRKGilead defended by analysts after recent pullback
Subscribe for More Information
10:18 EDTNOVNational Oilwell sees NOW spinoff completed in Q2
National Oilwell Varco announced that Marcela E. Donadio has been appointed to the National Oilwell Varco Board of Directors effective April 8. NOV also announced that NOW Inc. has filed its amended Form 10 with the Securities and Exchange Commission. The company anticipates the spin will be completed in 2Q14.
10:06 EDTXOM, CVXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:23 EDTMRKEuropean Association for the Study of the Liver to hold annual meeting
Subscribe for More Information
07:09 EDTMRKReckitt Benckiser may be frontrunner for Merck unit, Bloomberg reports
Subscribe for More Information
April 8, 2014
17:45 EDTCVXChevron initiated with a Buy at Jefferies
Subscribe for More Information
17:43 EDTXOMExxon Mobil initiated with a Hold at Jefferies
Subscribe for More Information
16:31 EDTBENFranklin Resources preliminary AUM $886.9B at March 31
Subscribe for More Information
11:03 EDTMRKPiper Jaffray's biopharm analyst holds an analyst/industry conference call
Biopharm Analyst Schimmer discusses PCSK9 Inhibitors and other atherosclerosis approaches on an Analyst/Industry conference call. Relevant companies AEGR, ALNY, AMGN, ARNA, AZN, BMY, CBST, LLY, ESPR, GSK, ICPT, ISIS, MNKD, MRK, OREX, PFE, REGN, RHHBY, SNY and VVUS may be included on the Analyst/Industry conference call to be held on April 10 at 3 pm.
April 7, 2014
14:09 EDTPRGOSun Pharmaceutical agrees to acquire generic drugmaker Ranbaxy
Subscribe for More Information
10:00 EDTMATOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:10 EDTMATOn The Fly: Pre-market Movers
HIGHER: Questcor (QCOR), up 27% after agreeing to be bought by Mallinckrodt (MNK) for cash, stock valued at $86.10 per Questcor share... Agios Pharmaceuticals (AGIO), up 25% after program shows "promising clinical activity" for advanced blood cancers, shares upgraded at JPMorgan... Vocus (VOCS), up 47% after agreeing to be acquired by GTCR for $446.5M, or $18.00 per share... Pandora (P), up 1.3% following upgrade at Wedbush. LOWER: MannKind (MNKD), down 13% after announcing FDA extension of PDUFA date for Afrezza... American Eagle (AEO), down 2.2% following downgrade at Cowen... Pfizer (PFE), down 2.8% after announcing data for palbociclib in metastatic breast cancer... Mattel (MAT), down 3% following downgrade at BMO Capital... WWE (WWE), down 1.2% after cautious mention in Barron's, company announcing WrestleMania 30 grossed $10.9M.
08:09 EDTMRKAlnylam's McSwiggen patent upheld in European opposition proceedings
Subscribe for More Information
07:27 EDTMRKAmerican Association of Cancer Research to hold annual meeting
Subscribe for More Information
06:04 EDTMATMattel downgraded to Underperform from Market Perform at BMO Capital
BMO Capital downgraded Mattel citing earnings risk from cyclical declines in Barbie and Hot Wheels, disappointing performance in Max Steel and Ever After High, and deteriorating sales in Monster High. The analyst sees continued deterioration in earnings given weak mature markets, challenges in emerging markets, and lack of sales leverage and cost savings opportunities. Price target lowered to $33 from 40.
April 6, 2014
13:37 EDTMRKMerck presents findings on clinical outcomes following treatment with MK-3475
Subscribe for More Information
April 4, 2014
15:31 EDTNOVNational Oilwell upgraded to Buy from Hold at Standpoint Research
Subscribe for More Information
10:02 EDTBENOn The Fly: Analyst Downgrade Summary
Antero Resources (AR) downgraded to Buy from Strong Buy at ISI Group... Cobalt (CIE) downgraded to Buy from Strong Buy at ISI Group... Franklin Resources (BEN) downgraded to Market Perform at Keefe Bruyette... Hasbro (HAS) downgraded to Hold from Buy at Needham... PPL Corp. (PPL) downgraded to Neutral from Outperform at Macquarie... Sonic (SONC) downgraded to Neutral from Buy at Buckingham... Vodafone (VOD) downgraded to Neutral from Buy at Nomura... AutoZone (AZO) downgraded to Neutral from Outperform at RW Baird... Advance Auto Parts (AAP) downgraded to Neutral from Outperform at RW Baird... LinnCo (LNCO) downgraded to Neutral from Buy at Citigroup... LINN Energy (LINE) downgraded to Neutral from Buy at Citigroup... General Mills (GIS) downgraded to Hold from Buy at Argus.
08:07 EDTMRKMerck, Ferring announce collaboration with WHO
Merck and Ferring Pharmaceuticals announced their collaboration with the World Health Organization to advance a new, proprietary formulation of carbetocin, used to prevent excessive bleeding in women after childbirth, that is designed to be stable at room temperature, even in hot and tropical climates. Currently, oxytocin, the standard medicine administered for the prevention of excessive bleeding, is temperature-sensitive and requires sustained cold distribution and storage in hot climates. The WHO will conduct a multi-country clinical study to evaluate the effectiveness of room-temperature-stable carbetocin, as compared to oxytocin. The development of a medicine that can be stored at room temperature has the potential to significantly improve management of bleeding following childbirth in the many areas of the world where cold storage is difficult to achieve and maintain, and thereby help reduce maternal deaths in those areas. Starting this year, the study will take place in 12 countries around the world and enroll approximately 29,000 women. If the results of the study are positive, the organizations will work together with the aim of making the medicine available in developing countries that have a high burden of maternal mortality at an affordable and sustainable public-sector price.
05:51 EDTBENFranklin Resources downgraded to Market Perform at Keefe Bruyette
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use